134 results

• Recalled Zantac OTC Brand Return To Market With Generic Pepcid Ingredient

  April 29, 2021

  Irvin Jackson

  This week, Sanofi announced intentions to re-launch Zantac under the name Zantac 360, which will use the active ingredient from Pepcid instead of ranitidine, which has been linked to increased cancer risks.

• Three Taxotere Cases Designated To Proceed With Discovery For Fourth Bellwether Trial

  January 4, 2021

  Irvin Jackson

  Three Taxotere hair loss lawsuits have been selected to serve as potential fourth bellwether trials over claims the chemotherapy drug's manufacturers failed to warn patients of the risk of permanent hair loss.

• Taxotere Bellwether Lawsuit Cleared To Proceed Before Jury, But Trial Date Postponed Due to COVID-19

  December 23, 2020

  Irvin Jackson

  A federal judge, after denying a flurry of summary judgment requests, has delayed the next Taxotere hair loss bellwether lawsuit, which was slated to go to trial in February.

• Depakine Side Effects Lead France To File Manslaughter Charges Against Sanofi

  August 4, 2020

  Irvin Jackson

  French authorities are pursuing a manslaughter investigation against Sanofi, following the deaths of four infants who died of birth defects linked to the epilepsy drug, Depakine.

• Hair Loss Lawsuits Over Taxotere Treatments After December 2015 Dismissed By Court

  June 5, 2020

  Irvin Jackson

  A federal judge has dismissed nearly 200 Taxotere lawsuits for being filed after the manufacturer added a warning to the label about permanent hair loss risks, but indicated the bulk of litigation will proceed and expanded the number of anticipated bellwether trials.

• Series of Four Taxotere Lawsuits Set For Trial in 2020 and 2021

  March 11, 2020

  Irvin Jackson

  Four bellwether trials over Taxotere hair loss claims will be held over the next two years, a federal judge has ordered.

• Gastric Cancer Lawsuit Filed Over Zantac NDMA Side Effects

  February 20, 2020

  Irvin Jackson

  A Zantac lawsuit indicates that high levels of NDMA in the heartburn drug resulted in a gastric cancer diagnosis.

• Class Action Lawsuit for Zantac Users Seeks Medical Monitoring For Cancer

  January 28, 2020

  Irvin Jackson

  A Zantac class action lawsuit calls for manufacturers to pay for the medical monitoring of anyone who took the drugs long-term and now faces an increased risk of cancer.

• Zantac Esophageal Cancer Lawsuit Filed Over Problems With Heartburn Drug

  January 8, 2020

  Irvin Jackson

  A Zantac lawsuit claims the recalled heartburn drugs caused a case of esophageal cancer due to NDMA contamination.

• Zantac Class Action Lawsuit Claims Manufacturers Exposed Public To Unsafe Levels Of Cancer-Causing Agent

  December 18, 2019

  Irvin Jackson

  A Zantac class action lawsuit claims manufacturers of the heartburn drug knowingly sold potentially cancer-causing drugs to the public for decades.